Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression

Orazio Palmieri1, Teresa Maria Creanza2,3, Fabrizio Bossa4

  • 1IRCCS 'Casa Sollievo della Sofferenza', Division of Gastroenterology, 71013 San Giovanni Rotondo, Italy. o.palmieri@operapadrepio.it.

Insights

This study reveals key microRNAs (miRNAs) involved in Crohn's disease (CD) pathogenesis by analyzing miRNA-mRNA interactions. Identifying these differential co-expression patterns offers new avenues for understanding CD and developing targeted therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Gastroenterology

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) influenced by genetic and environmental factors.
  • MicroRNAs (miRNAs) are implicated in IBD pathogenesis, with altered levels found in patient tissues and sera.

Purpose of the Study:

  • To identify differentially expressed miRNAs in inflamed versus non-inflamed Crohn's disease tissues.
  • To investigate altered miRNA-mRNA interactions and their impact on gene expression in CD.
  • To uncover miRNA-mediated regulatory mechanisms in CD.

Main Methods:

  • Comparison of miRNA and mRNA expression profiles between inflamed and non-inflamed tissue samples from CD patients.
  • Differential co-expression analysis of miRNA-mRNA interactions.
  • Gene set enrichment analysis to identify biological processes under altered miRNA control.

Main Results:

  • Identified 28 differentially expressed miRNAs (p < 0.01), with 14 upregulated.
  • Highlighted specific miRNAs (e.g., miR-4284, miR-3194, miR-21) with known roles in IBD mechanisms via differential co-expression analysis.
  • Demonstrated that differential expression analysis alone misses crucial miRNA-mRNA interactions.

Conclusions:

  • Differential miRNA-mRNA co-expression patterns are critical for understanding CD molecular mechanisms.
  • This approach identifies regulatory miRNAs missed by standard differential expression analysis.
  • Findings may lead to novel therapeutic targets for Crohn's disease.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K